Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Doxylamine Succinate

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 161Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Unisom® Partners with Saquon Barkley to Tackle Sleepless Nights
    Unisom® Partners with Saquon Barkley to Tackle Sleepless Nights

    02 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/unisom-and-saquon-barkley-team-up-to-tackle-sleepless-nights-for-football-fans-302341258.html

    PR NEWSWIRE
    02 Jan 2025
    Share Share
    Bionpharma's Generic Doxylamine Succinate, Pyridoxine Hydrochloride Receives Approval in the U.S.
    Bionpharma's Generic Doxylamine Succinate, Pyridoxine Hydrochloride Receives Approval in the U.S.

    04 Aug 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217000

    FDA
    04 Aug 2023
    Share Share
    Actavis Labs' Generic Doxylamine Succinate and Pyroxidine Hydrochloride Receives Approval in the U.S.
    Actavis Labs' Generic Doxylamine Succinate and Pyroxidine Hydrochloride Receives Approval in the U.S.

    01 Mar 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212472

    FDA
    01 Mar 2022
    Share Share
    Enforcement Report - Week of February 9, 2022
    Enforcement Report - Week of February 9, 2022

    09 Feb 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-9-2022-1644385243.pdf

    FDA
    09 Feb 2022
    Share Share
    Class 4 Medicine Defect Information: Xonvea 10 mg/10 mg gastro-resistant tablets
    Class 4 Medicine Defect Information: Xonvea 10 mg/10 mg gastro-resistant tablets

    17 Oct 2019

    // MHRA

    https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-xonvea-10-mg-10-mg-gastro-resistant-tablets-mdr-025-10-19

    MHRA
    17 Oct 2019
    Share Share
    Updated List of New Paragraph IV Patent Certifications - Oct 22
    Updated List of New Paragraph IV Patent Certifications - Oct 22

    01 Nov 2018

    // FDA

    https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/UCM293268.pdf

    FDA
    01 Nov 2018
    Share Share